New isolated nucleic acid comprising a nucleotide sequence of a bacterial replicon centromere, useful for treating infection caused by Burkholderia and glanders and melioidosis

Isolated nucleic acid (I) comprising a nucleotide sequence of a bacterial replicon centromere, is new. Independent claims are included for: (1) vector comprising one or more nucleic acids; and (2) antibacterial composition comprising (I) and/or the vector, in combination with a carrier. ACTIVITY : A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PASTA FRANCK, LANE HERBERT EDWIN DAVID, PASSOT FANNY, MARIE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Isolated nucleic acid (I) comprising a nucleotide sequence of a bacterial replicon centromere, is new. Independent claims are included for: (1) vector comprising one or more nucleic acids; and (2) antibacterial composition comprising (I) and/or the vector, in combination with a carrier. ACTIVITY : Antibacterial. MECHANISM OF ACTION : None given. La présente invention concerne un acide nucléique isolé comprenant la séquence nucléotidique d'un centromère de réplicon bactérien ou un fragment de celle-ci pour son utilisation comme médicament.